Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01302483 · ClinicalTrials.gov registry record · Phase 2
Safety and Effectiveness of Kovacaine Nasal Spray for Dental Anesthesia
A Phase 2 study, sponsored by St. Renatus.
- Completed
- Registry status
- Phase 2
- Development phase
- 45
- Enrollment target
NCT01302483: Completed Phase 2 study, sponsored by St. Renatus.
NCT01302483 is a Phase 2 study that has completed, run by St. Renatus. The registered enrollment target is 45 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (66% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01302483, a Phase 2 study, has completed, sponsored by St. Renatus.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study was to determine the safety and efficacy of Kovacaine Mist (3% tetracaine HCl with 0.05% oxymetazoline HCl) for anesthesia of the maxillary teeth for dental procedures.
Primary Outcome
Number of participants who did not need rescue anesthesia to complete the study dental procedure, i.e. Kovacaine provided enough pulpal anesthesia to complete a dental procedure.
Interventions
- DRUG 3% tetracaine HCL with 0.05% oxymetazoline HCL
- DRUG Lidocaine Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2008-12 |
| Est. Completion | 2009-01 |
| Phase | Phase 2 |
What the finished NCT01302483 record still lists
NCT01302483 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (66% lower).
The record links to 0 conditions, and to 2 interventions - of which 3% tetracaine HCL with 0.05% oxymetazoline HCL is the first listed.
NCT01302483 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01302483 about?
NCT01302483 is a clinical study titled "Safety and Effectiveness of Kovacaine Nasal Spray for Dental Anesthesia". The purpose of this study was to determine the safety and efficacy of Kovacaine Mist (3% tetracaine HCl with 0.05% oxymetazoline HCl) for anesthesia of the maxillary teeth for dental procedures.
What is the current status of trial NCT01302483?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 45 participants. The study started on 2008-12. Estimated completion is 2009-01.
What interventions are being tested in trial NCT01302483?
The interventions under investigation include: 3% tetracaine HCL with 0.05% oxymetazoline HCL (DRUG), Lidocaine Injection (DRUG).
Who is sponsoring clinical trial NCT01302483?
This trial is sponsored by St. Renatus, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01302483's enrollment target sits among peer trials
45 1296th of 2000 higher than 679 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia